Wednesday, 28 October 2026LatestVideosAboutContact
Latest
IPL team with culture like County club: Gareth Batty excited for project CSKCholamandalam Investment and Finance Q2 net up 41%, board approves fundraise up to ₹5000 cr via QIPNIT Rourkela scientists develop lead-free light-emitting materials for safer lighting and security applicationsCyclone eases after lashing India coast, no deaths reportedAdvent raises $30bn, starts mid-market fundJapan FA vice-president Takeshi Okada resigns over FIFA World Cup controversiesTata Projects wins GSFC order for phosphoric acid-sulphuric acid complex in GujaratHyundai Motor India Q2 FY27 profit slumps 24% to ₹1,196 cr as rising costs biteIndian miner Vedanta posts quarterly profit rise on surge in base metal pricesJain Irrigation signs deal for up to 19,000 tonnes of biochar creditsAnushka Sen joins Bonkers Corner as brand ambassadorComets probably didn't seed life on Earth after all, new study suggests
BusinessUpdated 1 hr ago

Piramal Pharma looks to a ‘significantly stronger’ second half of the year: Nandini Piramal

BusinessLine28 October 2026 at 2:42 pm IST
Image: BusinessLine

Company raises growth guidance to 19-20%; stock price soars over 17% on BSE

Continue reading on BusinessLine

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all

Advent raises $30bn, starts mid-market fund

Times of India10 min ago

Tata Projects wins GSFC order for phosphoric acid-sulphuric acid complex in Gujarat

BusinessLine10 min ago2 sources

Hyundai Motor India Q2 FY27 profit slumps 24% to ₹1,196 cr as rising costs bite

BusinessLine11 min ago

Indian miner Vedanta posts quarterly profit rise on surge in base metal prices

BusinessLine12 min ago